Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation
Aileen C. Johnson, Joan Zhang, Geeta Karadkhele, Loren Gragert, Vicki Hertzberg, Christian P. Larsen
Topics & Concepts
BelataceptMedicineImmunosuppressionHazard ratioTacrolimusKidney transplantationInternal medicineTransplantationOncologyKidney transplantConfidence intervalRenal Transplantation Outcomes and TreatmentsOrgan Transplantation Techniques and OutcomesTransplantation: Methods and Outcomes